ImmunoChemistry Technologies Newsroom

Check out the latest press releases and newsletters from ImmunoChemistry Technologies. For direct media requests, contact us at sally@immunochemistry.com.

 

October 29, 2014 – ImmunoChemistry Technologies Sells Patent for its Proprietary Technology

FLIVO®, which detects cell death in living animals, is now on track for further development and use in cancer research.

 

September 22, 2014 – We’re CELL-elebrating our 20th Anniversary

ImmunoChemistry Technologies will celebrate 20 Years of Solutions all throughout the coming year.

 

February 25, 2014 – ICT Introduces Two HRP Conjugate Stabilizers

New conjugate stabilizer formulations prolong the shelf-life of conjugated antibodies and reduce non-specific binding during conjugate incubation.

 

January 21, 2014 – ICT Introduces Two New ELISA Blocking Buffer Formulations

New blocking buffer formulations offer additional choices to perform this crucial immunoassay step.

 

December 03, 2013ImmunoChemistry Technologies Changes Ownership

Biomedical Lab developing proprietary and patented reagents for cancer research is now majority women-owned.

 

September 19, 2013ImmunoChemistry Technologies Celebrates 19th Anniversary

ImmunoChemistry Technologies is now celebrating its 20th Year of Solutions.

 

June 20, 2013 – New Product Release: Far-Red Fluorescent FLICA® 660 Caspase-3 Assay

New assay introduces a far-red fluorescent option for in vitro apoptosis detection.

 

Our Pressroom on PRLog

Media Backgrounder